Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


10.12.2018

3 BMC Cancer
1 Cancer
1 Childs Nerv Syst
2 Clin Cancer Res
5 J Neurooncol
1 Neuro Oncol
1 Neurology
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. TAN WL, Ng QS, Lim C, Tan EH, et al
    Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases.
    BMC Cancer. 2018;18:1198.
    PubMed     Text format     Abstract available

  2. LI L, Huang Y, Gao Y, Shi T, et al
    EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence.
    BMC Cancer. 2018;18:1215.
    PubMed     Text format     Abstract available

  3. MONNIER A, Boniface R, Bouvet R, Etcheverry A, et al
    The expression of EMX2 lead to cell cycle arrest in glioblastoma cell line.
    BMC Cancer. 2018;18:1213.
    PubMed     Text format     Abstract available


    Cancer

  4. GEURTS M, van den Bent MJ
    On high-risk, low-grade glioma: What distinguishes high from low?
    Cancer. 2018 Dec 4. doi: 10.1002/cncr.31834.
    PubMed     Text format    


    Childs Nerv Syst

  5. NAPIERALSKA A, Braclik I, Radwan M, Mandera M, et al
    Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma.
    Childs Nerv Syst. 2018 Dec 4. pii: 10.1007/s00381-018-4010.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  6. INDRACCOLO S, Lombardi G, Fassan M, Pasqualini L, et al
    Genetic, epigenetic and immunologic profiling of MMR-deficient relapsed glioblastoma.
    Clin Cancer Res. 2018 Dec 4. pii: 1078-0432.CCR-18-1892.
    PubMed     Text format     Abstract available

  7. HEGI ME, Genbrugge E, Gorlia T, Stupp R, et al
    MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide. A Pooled Analysis of Four Clinical Trials.
    Clin Cancer Res. 2018 Dec 4. pii: 1078-0432.CCR-18-3181.
    PubMed     Text format     Abstract available


    J Neurooncol

  8. NAVARRIA P, Minniti G, Clerici E, Tomatis S, et al
    Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO).
    J Neurooncol. 2018 Dec 4. pii: 10.1007/s11060-018-03059.
    PubMed     Text format     Abstract available

  9. LU VM, Goyal A, Lee A, Jentoft M, et al
    The prognostic significance of TERT promoter mutations in meningioma: a systematic review and meta-analysis.
    J Neurooncol. 2018 Dec 1. pii: 10.1007/s11060-018-03067.
    PubMed     Text format     Abstract available

  10. TOMS SA, Kim CY, Nicholas G, Ram Z, et al
    Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial.
    J Neurooncol. 2018 Dec 1. pii: 10.1007/s11060-018-03057.
    PubMed     Text format     Abstract available

  11. GRAUER O, Jaber M, Hess K, Weckesser M, et al
    Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients.
    J Neurooncol. 2018 Dec 1. pii: 10.1007/s11060-018-03005.
    PubMed     Text format     Abstract available

  12. HAIDER SA, Lim S, Kalkanis SN, Lee IY, et al
    The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
    J Neurooncol. 2018 Dec 1. pii: 10.1007/s11060-018-03061.
    PubMed     Text format     Abstract available


    Neuro Oncol

  13. NARITA Y, Arakawa Y, Yamasaki F, Nishikawa R, et al
    A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.
    Neuro Oncol. 2018 Nov 30. pii: 5219198. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neurology

  14. ROUX A, Edjlali M, Porelli S, Tauziede-Espariat A, et al
    Developmental venous anomaly in adult patients with diffuse glioma: A clinically relevant coexistence?
    Neurology. 2018 Nov 30. pii: WNL.0000000000006690.
    PubMed     Text format     Abstract available


    PLoS One

  15. SELIGER C, Schaertl J, Gerken M, Luber C, et al
    Use of statins or NSAIDs and survival of patients with high-grade glioma.
    PLoS One. 2018;13:e0207858.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: